Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0604620090160010342
Dongguk Journal of Medicine
2009 Volume.16 No. 1 p.342 ~ p.347
A Case of Topical Application of Bevacizumab on Corneal Neovascularization after Herpes Keratitis
Seok Su-Sie

Suh Eok-Soo
Jung Bo-Young
Kim Ho-Chang
Abstract
Corneal neovascularization occur as a result of disequilibrium between angiogenic and antiangiogenic stimuli, caused by inflammation, ischemia and truama. VEFG is a important factor of corneal neovascularization. 64 year-old man with herpetic keratitis presented with a complant of decreased vision. He also presented with ocular surface inflammation and corneal new vessels on the whole cornea. He received 1.25% topical bevacizumab twice daily that is directed against VGEF. Ophthalmic evaluation included visual acuity and slit-lamp examination. 4 months later, topically administered bevacizumab reduces corneal new vessles and corneal opacity.
KEYWORD
bevacizumab, corneal neovascularization, herpes keratitis
FullTexts / Linksout information
Listed journal information